Green Cross Medical Science Corporation

Informe acción KOSDAQ:A142280

Capitalización de mercado: ₩86.2b

Green Cross Medical Science Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Won-Sub Gil

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO11.3yrs
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated

Mar 26
We Think Green Cross Medical Science's (KOSDAQ:142280) Solid Earnings Are Understated

Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings

Mar 23
Investors Shouldn't Be Too Comfortable With Green Cross Medical Science's (KOSDAQ:142280) Robust Earnings

These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively

Feb 24
These 4 Measures Indicate That Green Cross Medical Science (KOSDAQ:142280) Is Using Debt Extensively

Is Green Cross Medical Science's (KOSDAQ:142280) Share Price Gain Of 128% Well Earned?

Jan 28
Is Green Cross Medical Science's (KOSDAQ:142280) Share Price Gain Of 128% Well Earned?

Is Green Cross Medical Science Corporation (KOSDAQ:142280) Popular Amongst Insiders?

Jan 02
Is Green Cross Medical Science Corporation (KOSDAQ:142280) Popular Amongst Insiders?

Should We Be Excited About The Trends Of Returns At Green Cross Medical Science (KOSDAQ:142280)?

Dec 07
Should We Be Excited About The Trends Of Returns At Green Cross Medical Science (KOSDAQ:142280)?

CEO

Won-Sub Gil

11.3yrs

Permanencia

Won-Sub Gil has been Chief Executive Officer at GreenCross Medical Science Corp. since 2013. Won-Sub Gil served as Director of Production Division of GreenCross Medical Science Corporation from 2008 to 201...